Avanir Pharmaceuticals (AVNR) Tops Q3 EPS by 3c
Tweet Send to a Friend
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q3 EPS of ($0.08), $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
